Cargando…
The protein tyrosine phosphatase 1B inhibitor MSI-1436 stimulates regeneration of heart and multiple other tissues
Regenerative medicine holds substantial promise for repairing or replacing tissues and organs damaged by disease, injury, and degeneration. Much of the field has focused on development of cell-based therapeutics, gene-based therapeutics, and tissue engineering-based therapeutics. In contrast, develo...
Autores principales: | Smith, Ashley M., Maguire-Nguyen, Katie K., Rando, Thomas A., Zasloff, Michael A., Strange, Kevin B., Yin, Viravuth P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5677970/ https://www.ncbi.nlm.nih.gov/pubmed/29302341 http://dx.doi.org/10.1038/s41536-017-0008-1 |
Ejemplares similares
-
MSI-1436 improves EMS adipose derived progenitor stem cells in the course of adipogenic differentiation through modulation of ER stress, apoptosis, and oxidative stress
por: Bourebaba, Lynda, et al.
Publicado: (2021) -
The PTP1B Inhibitor Trodusquemine (MSI-1436) Improves Glucose Uptake in Equine Metabolic Syndrome Affected Liver through Anti-Inflammatory and Antifibrotic Activity
por: Bourebaba, Lynda, et al.
Publicado: (2023) -
The PTP1B selective inhibitor MSI-1436 mitigates Tunicamycin-induced ER stress in human hepatocarcinoma cell line through XBP1 splicing modulation
por: Bourebaba, Lynda, et al.
Publicado: (2023) -
The PTP1B inhibitor MSI-1436 ameliorates liver insulin sensitivity by modulating autophagy, ER stress and systemic inflammation in Equine metabolic syndrome affected horses
por: Bourebaba, Lynda, et al.
Publicado: (2023) -
P1436: AGEING IMPACTS HYDROXYCARBAMIDE DOSING IN PATIENTS WITH SICKLE CELL DISEASE
por: Doss, Isabelle, et al.
Publicado: (2023)